PNC Financial Services Group’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1
Closed -$70 5246
2025
Q3
$70 Buy
+1
New +$496 ﹤0.01% 5020
2024
Q4
Hold
0
-$114 4867
2024
Q3
Hold
0
4715
2024
Q2
Hold
0
4701
2024
Q1
Hold
0
4622
2022
Q2
Hold
0
4610
2022
Q1
Hold
0
4618
2021
Q4
Hold
0
4529
2021
Q3
Hold
0
4200
2021
Q2
Hold
0
3883
2021
Q1
Hold
0
3819
2020
Q4
Hold
0
3707
2020
Q3
Hold
0
3634
2020
Q2
Hold
0
3562
2020
Q1
Hold
0
3556
2019
Q4
Hold
0
3890
2019
Q3
Hold
0
3860
2019
Q2
Hold
0
3828
2019
Q1
Hold
0
3778
2018
Q4
Hold
0
3857
2018
Q3
Hold
0
3900
2018
Q2
Hold
0
3880
2018
Q1
Hold
0
3890
2017
Q4
Hold
0
3818

Other funds holding KALA

PNC Financial Services Group's KALA Position: Q4 2025 in Review

PNC Financial Services Group sold out of KALA BIO (KALA) in Q4 2025, closing a stake of 1 share — an estimated $70 sold.

PNC Financial Services Group first reported a position in KALA in Q3 2025 and held it in 1 quarter. The position peaked at $70 in Q3 2025. 29 funds tracked by Wall St. Rank hold KALA as of Q4 2025.

  • PNC Financial Services Group reported no remaining KALA BIO position as of Q4 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 1 KALA BIO share in Q4 2025, an estimated $70.
  • PNC Financial Services Group first reported a position in KALA BIO in Q3 2025 and held it in 1 quarter.
  • PNC Financial Services Group's KALA BIO position peaked at $70 in Q3 2025.
  • 29 funds tracked by Wall St. Rank held KALA BIO as of Q4 2025.

Based on PNC Financial Services Group's 13F filing for Q4 2025, filed 6 Feb 2026.